Stock NAOV NANOVIBRONIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News NanoVibronix, Inc.

Equities

NAOV

US63008J6038

Market Closed - Nasdaq
Other stock markets
 21:30:00 28/06/2024 BST 		5-day change 1st Jan Change
0.7 USD -1.80% Intraday chart for NanoVibronix, Inc. -4.77% -39.13%
05-22 NanoVibronix, Inc. Announces Commencement of UroShield Clinical Study at the University of Michigan CI
05-15 NanoVibronix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
BU
NanoVibronix, Inc. Announces Commencement of UroShield Clinical Study at the University of Michigan
CI
NanoVibronix Issues Letter to Stockholders
BU
NanoVibronix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield
MT
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
BU
NanoVibronix, Inc. Announces Distribution Agreement with Cb Medical, Llc for the Distribution of Uroshield
CI
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
BU
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs? FSS Contract Award
CI
NanoVibronix : Failure to Satisfy Listing Rule - Form 8-K
PU
NanoVibronix Issues Letter to Stockholders
BU
NanoVibronix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
BU
NanoVibronix Featured in Your Bladder Health Magazine
BU
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
BU
NanoVibronix, Inc. Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
CI
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
BU
NanoVibronix, Inc. Signs Research Agreement for Clinical Study of UroShield with University of Michigan
CI
NanoVibronix Regains Nasdaq Compliance
BU
NanoVibronix Issues Letter to Shareholders
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NAOV Stock
  4. News NanoVibronix, Inc.